Although there was no difference in the ApoB/ApoA1 ratio between the two groups at both assessments, a significant reduction in this ratio was noted in the MetS group following the implementation of the lifestyle intervention program, which is also consistent with a decrease in the inflammatory process (p < 0.01) (Table 3). The gene discussed is APOA1; the disease is metabolic syndrome.